PTC Therapeutics
PTCT
#2687
Rank
โ‚ฌ5.32 B
Marketcap
66,35ย โ‚ฌ
Share price
-0.76%
Change (1 day)
45.93%
Change (1 year)

PTC Therapeutics (PTCT) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚ฌ2.27 Billion

According to PTC Therapeutics 's latest financial reports the company's total assets are โ‚ฌ2.27 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

PTC Therapeutics - Total assets on balance sheet (from 2012 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ1.63 B-4.45%
2023-12-31โ‚ฌ1.71 B7.85%
2022-12-31โ‚ฌ1.59 B-7.08%
2021-12-31โ‚ฌ1.71 B-4.68%
2020-12-31โ‚ฌ1.79 B23.86%
2019-12-31โ‚ฌ1.44 B48.16%
2018-12-31โ‚ฌ0.97 B199.72%
2017-12-31โ‚ฌ0.32 B27.47%
2016-12-31โ‚ฌ0.25 B-23.35%
2015-12-31โ‚ฌ0.33 B21.93%
2014-12-31โ‚ฌ0.27 B149.09%
2013-12-31โ‚ฌ0.10 B1013.02%
2012-12-31โ‚ฌ9.88 M-70.93%
2011-12-31โ‚ฌ33.99 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Vertex Pharmaceuticals
VRTX
โ‚ฌ21.35 B 840.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚ฌ3.00 B 32.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
โ‚ฌ0.29 B-87.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
โ‚ฌ1.83 B-19.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚ฌ0.74 B-67.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ92.15 B 3,958.29%๐Ÿ‡จ๐Ÿ‡ญ Switzerland